Hematological Malignancies

GHSG HD10 Study Overall Survival

Overall Survival 0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0 0 12

5y-FFTF difference 0,5% 95% CI [-2,6%; 1,6%]

p=0,92

4xABVD

2xABVD

24

36

48

60

72

84

96

108

120

Time [months]

Engert et al NEJM 2010